Real-time enrollment status for this moderately to severely active ulcerative colitis clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:53 PM UTC
| NCT Number | NCT07158242 |
| Recruiting Status | Recruiting |
| Condition | Moderately to Severely Active Ulcerative Colitis |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT07158242 is currently recruiting participants. This phase3 study for moderately to severely active ulcerative colitis is actively seeking new participants at 8 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07158242 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07158242 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.